Speaker illustration

Doctor Tamer El Andere

Institute Dante Pazzanese of Cardiology, Sao Paulo (Brazil)

A resident in Arrythmology, living in São Paulo, Brazil, who's looking forward to becoming a great professional and researcher.

Are we being able to meet current guidelines LDL-cholesterol goals in very high risk patients? How many of them could benefit of PSCK9 inhibition by the FOURIER/ODYSSEY and NICE criteria?

Event: ESC CONGRESS 2019

Topic: Scores

Session: Lipids

Thumbnail

This platform is supported by

logo Novo Nordisk